Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.875 USD | +3.21% | -0.63% | +21.85% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.85% | 484M | |
-0.28% | 90.59B | |
0.00% | 38.99B | |
-9.26% | 34.09B | |
+64.13% | 26.38B | |
-18.47% | 15.02B | |
-6.24% | 13.17B | |
-10.69% | 11.88B | |
-47.78% | 10.65B | |
+8.09% | 9.25B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices Receives Nasdaq Noncompliance Notice